New drugs 2003, part I.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pa, USA.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002227:Carbazoles / Q000009:adverse effects / Q000627:therapeutic use; D004358:Drug Therapy / Q000451:nursing*; D000077727:Ertapenem; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D007769:Lactams; D008881:Migraine Disorders / Q000188:drug therapy; D000068557:Olmesartan Medoxomil; D004364:Pharmaceutical Preparations; D013777:Tetrazoles / Q000009:adverse effects / Q000627:therapeutic use; D014363:Tryptamines; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D002227:Carbazoles; D007093:Imidazoles; D007769:Lactams; D004364:Pharmaceutical Preparations; D013777:Tetrazoles; D014363:Tryptamines; D047090:beta-Lactams; D000068557:Olmesartan Medoxomil; D000077727:Ertapenem; C108128:frovatriptan